VMP 37082411000001106

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Carbamazepine 200mg modified-release tablets
BNF code 0408010C0AAAGAG
Virtual Therapeutic Moiety Carbamazepine
Date identifier became valid 25 Apr 2019
Previous product identifier 322883000
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Caution - AMP level prescribing advised
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Carbamazepine
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 200.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tabletmodified-release.oral
Dose Form
Formulation Modified-release tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Carbamazepine 200mg modified-release tablets (Medreich Plc)
Curatil Prolonged Release 200mg tablets (Tillomed Laboratories Ltd)
Tegretol Prolonged Release 200mg tablets (Lexon (UK) Ltd)
Tegretol Prolonged Release 200mg tablets (Novartis Pharmaceuticals UK Ltd)
Tegretol Prolonged Release 200mg tablets (Pharmaram Ltd)
Tegretol Prolonged Release 200mg tablets (Sigma Pharmaceuticals Plc)
Virtual Medicinal Product Packs
Carbamazepine 200mg modified-release tablets 100 tablet
Carbamazepine 200mg modified-release tablets 30 tablet
Carbamazepine 200mg modified-release tablets 50 tablet
Carbamazepine 200mg modified-release tablets 56 tablet
Carbamazepine 200mg modified-release tablets 60 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.

Feedback